Chronic myeloid leukemia (CML) is a malignant clonal disorder of the hematopoietic system caused by the expression of the BCR/ABL fusion oncogene. Although it is well known that CML cells are genetically unstable, the mechanisms accounting for this genomic instability are still poorly understood. Because the Fanconi anemia (FA) pathway is believed to control several mechanisms of DNA repair, we investigated whether this pathway was disrupted in CML cells. Our data show that CML cell
Chronic myeloid leukemia (CML) is characterized by the increased and un-regulated proliferation of m...
1.1 Genomic and chromosomal instability in CML An unstable genome is a common hallmark of nearly all...
Genomic instability is a common feature of cancer cells, which can result from aberrant DNA damage r...
Chronic myeloid leukemia (CML) is a malignant clonal disorder of the hematopoietic system caused by ...
Chronic myeloid leukemia (CML) is a malignant clonal disorder of the hematopoietic system caused by ...
This work was supported by grants from the European Program "Life Sciences, Genomics and Biotechnolo...
Chronic myeloid leukaemia (CML) is a myeloproliferative disorder arising in the haemopoietic stem ce...
The most recent two decades have seen tremendous progress in the understanding and treatment of chro...
Chronic myeloid leukaemia (CML) is caused by the product of the BCR-ABL oncogene, located on the Phi...
Chronic myelogenous leukemia (CML) evolves from a chronic phase characterized by the Philadelphia ch...
Chronic myeloid leukemia (CML) is typified by robust marrow and extramedullary myeloid cell producti...
Chronic myelogenous leukemia (CML), characterized by the BCR-ABL gene rearrangement, has been extens...
Chronic myelogenous leukemia (CML) is a disease arising from a reciprocal translocation between chro...
Cytogenetic and enzymatic studies have shown that chronic myeloid leukemia (CML) represents the clon...
Chronic myelogenous leukemia (CML) is a neoplastic disorder of pluripotent hematopoietic stem cells ...
Chronic myeloid leukemia (CML) is characterized by the increased and un-regulated proliferation of m...
1.1 Genomic and chromosomal instability in CML An unstable genome is a common hallmark of nearly all...
Genomic instability is a common feature of cancer cells, which can result from aberrant DNA damage r...
Chronic myeloid leukemia (CML) is a malignant clonal disorder of the hematopoietic system caused by ...
Chronic myeloid leukemia (CML) is a malignant clonal disorder of the hematopoietic system caused by ...
This work was supported by grants from the European Program "Life Sciences, Genomics and Biotechnolo...
Chronic myeloid leukaemia (CML) is a myeloproliferative disorder arising in the haemopoietic stem ce...
The most recent two decades have seen tremendous progress in the understanding and treatment of chro...
Chronic myeloid leukaemia (CML) is caused by the product of the BCR-ABL oncogene, located on the Phi...
Chronic myelogenous leukemia (CML) evolves from a chronic phase characterized by the Philadelphia ch...
Chronic myeloid leukemia (CML) is typified by robust marrow and extramedullary myeloid cell producti...
Chronic myelogenous leukemia (CML), characterized by the BCR-ABL gene rearrangement, has been extens...
Chronic myelogenous leukemia (CML) is a disease arising from a reciprocal translocation between chro...
Cytogenetic and enzymatic studies have shown that chronic myeloid leukemia (CML) represents the clon...
Chronic myelogenous leukemia (CML) is a neoplastic disorder of pluripotent hematopoietic stem cells ...
Chronic myeloid leukemia (CML) is characterized by the increased and un-regulated proliferation of m...
1.1 Genomic and chromosomal instability in CML An unstable genome is a common hallmark of nearly all...
Genomic instability is a common feature of cancer cells, which can result from aberrant DNA damage r...